The ADAMTS2 gene helps prepare collagen, a key support protein that gives skin and other connective tissues strength. In medicine, this gene is important because it helps regulate the final trimming steps that let collagen fibers form normally. If the gene does not work well, connective tissue can become unusually fragile, which may lead to very stretchy skin, easy bruising, hernias, and poor wound healing. Pathogenic variants in the ADAMTS2 gene are linked to dermatosparaxis Ehlers-Danlos syndrome, a rare inherited condition.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the code for proteins, the parts of cells that do the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this topic further, you can find more in LearnHub.
Overview
ADAMTS2Gene function
What if the gene works
The ADAMTS2 gene helps your body prepare collagen, a protein that gives skin, tendons, and other tissues strength. Its protein trims newly made collagen so it can form strong, organized fibers.
Risk
What if the gene does not work
More disruptive variants in the ADAMTS2 gene cause dermatosparaxis Ehlers-Danlos syndrome, marked by fragile, loose skin, easy bruising, and large hernias. Milder variants can leave some enzyme activity, which may influence when features appear and how pronounced they are.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic variants in the ADAMTS2 gene. Management remains supportive and guided by a person’s symptoms rather than the gene change itself. The ADAMTS2 gene is being studied in early research as a possible biomarker and tissue remodeling target in some cancers and fibrotic conditions.
Conditions associated with ADAMTS2
Gene function
What if the gene works
Your body uses the ADAMTS2 gene to help newly made collagen become ready for use. Collagen is a major building material in skin, tendons, ligaments, and other connective tissues. Understanding how the ADAMTS2 gene helps collagen form normally makes it easier to see how tissues keep their usual shape and strength.
The ADAMTS2 gene helps remove extra pieces from newly made procollagen, the early form of collagen. This step turns it into mature collagen that is ready to join with other collagen molecules.
Once collagen is trimmed, the ADAMTS2 protein helps those molecules line up and pack into sturdy fibers. These fibers give connective tissue its usual framework and support.
By helping collagen fibers form in an orderly way, this gene supports the material between cells, called the extracellular matrix. That framework helps skin and other tissues handle everyday stretching and movement.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many do not produce any noticeable effect and are simply part of natural genetic variation. At times, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
ADAMTS2 gene variants can weaken or switch off the protein that trims procollagen before it is assembled into collagen fibers. Some changes, often missense variants, may leave partial activity, while more disruptive variants such as nonsense, frameshift, or splice changes can leave little or no working protein. This helps explain how ADAMTS2 gene variants affect collagen processing and why dermatosparaxis Ehlers-Danlos syndrome may start earlier or be more noticeable in some people.
How variants are linked to conditions
Pathogenic variants in the ADAMTS2 gene cause dermatosparaxis Ehlers-Danlos syndrome, a rare inherited connective tissue condition. This ADAMTS2 gene condition is linked to very fragile, loose skin, easy bruising, and a higher chance of hernias. The diagnosis is usually confirmed when a person has disease-causing variants in both copies of the ADAMTS2 gene.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ADAMTS2, risk is mainly shaped by inheritance rather than lifestyle. A child is affected when they inherit harmful ADAMTS2 changes from both parents, so risk is higher in families with a known ADAMTS2 change and where the parents are related by blood, such as cousins.
Inheritance of ADAMTS2 variants
Variants in the ADAMTS2 gene linked to ADAMTS2-related Ehlers-Danlos syndrome are inherited in an autosomal recessive pattern. This means a child inherits one altered copy from each parent. Parents who each carry one ADAMTS2 gene variant usually do not have the condition themselves, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. Because the ADAMTS2 gene is on chromosome 5, this inheritance pattern is the same for males and females.
What does my ADAMTS2 result mean for my family?
For ADAMTS2-related Ehlers-Danlos syndrome, the family pattern is usually recessive, so close relatives can sometimes carry the same gene change without having symptoms. Brothers and sisters may also be affected or may be carriers, and parents are often carriers. For many living with an ADAMTS2 result, this means family members may want to learn whether the same change runs in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ADAMTS2 variants uses a blood or saliva sample to read the ADAMTS2 gene and look for changes linked with dermatosparaxis type Ehlers-Danlos syndrome. Results can confirm a diagnosis when a disease-causing variant is found, or show an uncertain finding that needs clinical interpretation.
When should I consider getting a genetic test?
Consider ADAMTS2 genetic testing if someone has signs of the very rare dermatosparaxis type of Ehlers-Danlos syndrome, such as very fragile, loose skin, easy bruising, and hernias from early life. Testing can also help when this condition runs in the family or both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the kind of variant. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when considered together with the rest of care. In other situations, a genetic result may give a clear answer. For areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body absorbs, breaks down, moves, or responds to a drug. This helps explain why the same medicine may work well for one person, help less in another, or cause more side effects in someone else. These differences are common and are only one part of the picture, alongside age, overall health, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the ADAMTS2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor.
History
Throughout history, people described unusually fragile, sagging skin in both animals and humans long before the cause was clear. In the 1970s and 1980s, researchers linked these findings to a missing collagen-processing step, first recognized in dermatosparaxis in cattle and later in a rare human form of Ehlers-Danlos syndrome. Building on this early work, scientists identified the ADAMTS2 gene in the 1990s as the gene behind this inherited pattern. That discovery helped connect earlier clinical observations with a specific genetic cause and clarified why similar features could appear across species. Over time, descriptions became more precise as genetic testing confirmed ADAMTS2-related cases in affected families.